Trial title not recorded
Disseminated Intravascular Coagulation
Enrolment: 40 · Results not recorded
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Disseminated Intravascular Coagulation
Enrolment: 40 · Results not recorded
Severe Sepsis · Coagulopathy
Enrolment: 816 · Results not recorded
Idiopathic Pulmonary Fibrosis
Enrolment: 74 · Results not recorded
Sepsis and Coagulopathy
Enrolment: 0 · Results not recorded
Sepsis · Disseminated Intravascular Coagulation
Enrolment: 750 · Results not recorded
Postoperative Stage II/III Colon Cancer
Enrolment: 79 · Results not recorded
Chemotherapy-induced Peripheral Neuropathy
Enrolment: 0 · Results not recorded
Sepsis
Enrolment: 2000 · Results not recorded
Chemotherapy-induced Peripheral Neuropathy
Enrolment: 77 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Lipopolysaccharide-induced endotoxaemia and acute respiratory distress syndrome, LPS 20 mg/kg intraperitoneally after 16 hours starvation
rhTM improved survival relative to controls at 48 hours after LPS, lowered serum IL-6 and HMGB1, attenuated pulmonary capillary endothelial glycocalyx injury and preserved glycocalyx synthesis gene and protein expression.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.